HomeAI · summaries
Storia in 2 fonti
Behind the headlines of ASCO 2026
Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s ann | Each year, the global oncology community descends on Chicago for ASCO, where buzzy data drops, practice-changing posters and packed sessions offer a look at where cancer care is headed next. In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Fierce Pharma’s Zoey Becker and Angus Liu break down the biggest takeaways from their weekend reporting live from the Windy City, from “nutty” in vivo CAR-T data to a historic first for a Chinese biotech asset.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
pharmaceutical-technology.com
ASCO26: Blood cancer readouts take centre stage - Pharmaceutical Technology
Readouts in rare blood cancers like myelofibrosis, WM and CLL are attracting keen interest at this year’s ASCO conference.
- ·
fiercepharma.com
As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
In 2017, a little-known company called Nanjing Legend Biotech walked into the ASCO annual meeting at the 11th hour, dropped a 100% objective response rate for a cell therapy that…
- ·
Coffee, racetracks, beaches and more coffee—inside the ASCO 2026 exhibit floor
There were 487 exhibitor booths at the American Society of Clinical Oncology (ASCO)’s 2026 annual meeting, held in Chicago’s McCormick Place. Fierce Pharma Marketing attempted to…
- ·
Accelerating Targeted Gene Expression Analysis in Drug Development
Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR…
- ·
Behind the headlines of ASCO 2026
Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s ann | Each year, the global oncology community descends on…